stem cells
-
Thomas Smeenk Discusses the Intersection of Hemostemix’s NCP Treatment and Elon Musk’s Neuralink
In this InvestorIntel interview, Tracy Weslosky talks with Hemostemix Inc.’s (TSXV: HEM | OTCQB: HMTXF) Co-Founder, CEO, and President…
-
Hemostemix posts promising clinical trial results from heart failure and limb ischemia treatment
Heart failure (HF) is a growing epidemic in the United States, with an estimated 6 million people affected.…
-
Thomas Smeenk on Hemostemix products for Your Fountain of Youth
In a recent InvestorIntel interview, Tracy Weslosky spoke with Thomas Smeenk, Co-Founder, President and CEO of Hemostemix Inc. (TSXV:…